News & Updates

In patients with multiple myeloma (MM), the chromosome translocation t(11;14) does not seem to be associated with worse prognosis, resulting in similar treatment outcomes as other standard-risk subgroups, reports a recent study.

Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.

Pre-existing cardiovascular disease (CVD) and grade 3 Scarff Bloom-Richardson are associated with the occurrence of cardiovascular (CV) events among women with breast cancer, reports a study.

Both surgery and use of stereotactic body radiation therapy (SBRT) result in a decrease in the mean tumour size of early-stage nonsmall cell lung cancer (NSCLC), a recent study has shown.

First-line maintenance therapy with niraparib at an individualized starting dose (ISD) improved progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer, according to results of the phase III PRIME study presented at SGO 2022.